CLINICAL_TRIALS
trial_result
· 2012-05-18
Clinical Trial Update: Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast [NA]
Summary
Clinical trial update on neoadjuvant Herceptin for ductal carcinoma in situ of the breast has completed with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Ductal Carcinoma In Situ | NA | Status: COMPLETED | Results posted: 2012-05-18